Search
for
Sort by
Research 61–90 of 1000+
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Efficacy of an agonist of<i>α</i>-MSH, the palmitoyl tetrapeptide-20, in hair pigmentation
- Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- PPAR-<i>γ</i> Agonists and Their Role in Primary Cicatricial Alopecia
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Hair Growth Promotion by δ-Opioid Receptor Activation
- Molecular docking of Vitamin D3 Receptor (VDR) with potential herbal substance as ligand to prevent excessive hair loss in menopausal women
- Thyroid receptor β: A promising target for developing novel anti-androgenetic alopecia drugs
- Quantification of the Vitamin D Receptor−Coregulator Interaction
- Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands
- Expression of retinoid nuclear receptor superfamily members in human hair follicles and its implication in hair growth.
- Activation of the Human Transient Receptor Potential Vanilloid Subtype 1 by Essential Oils
- The effects of GPR40 agonists on hair growth are mediated by ANGPTL4
- Peroxisome Proliferator Activated Receptors Gamma Serum levels and Gene Polymorphism in Frontal Fibrosing Alopecia: A Case Control Study
- 571 Human Hair Follicles can “Taste”: Stimulation of the Bitter Taste Receptor TAS2R4 Inhibits Hair Growth Ex Vivo by Up-Regulating TGF-β2
- 223 Canonical and Dominant Negative Peroxisome Proliferator-Activated Receptor γ Isoforms are Differentially Expressed in Human Skin and Skin Appendages
- Pharmacological activation of estrogen receptors-α and -β differentially modulates keratinocyte differentiation with functional impact on wound healing
- Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases
- Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in Modulating Preexisting Dermatologic Disease: A Systematic Review
- A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes<i>in vitro</i>and<i>in situ</i>
- Functions of peroxisome proliferator‐activated receptors (PPAR) in skin homeostasis
- Glucagon-like peptide-1 receptor and proglucagon expression in mouse skin
- Therapeutic Strategies to Target the Androgen Receptor
- LPA3, a unique G protein-coupled receptor for lysophosphatidic acid
- Molecular studies of transient receptor potential Vanilloid 3 (TRPV3)
- A neuroendocrinological perspective on human hair follicle pigmentation
- Alopecia and Semaglutide: Connecting the Dots for Patient Safety
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)